TriSalus Total Assets from 2010 to 2026
| TLSI Stock | 6.98 0.34 5.12% |
Total Assets | First Reported 2020-09-30 | Previous Quarter 41.3 M | Current Value 36.5 M | Quarterly Volatility 100.4 M |
Check TriSalus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TriSalus Life's main balance sheet or income statement drivers, such as Tax Provision of 7.4 K, Interest Income of 279.1 K or Interest Expense of 3.7 M, as well as many indicators such as Price To Sales Ratio of 4.93, Dividend Yield of 0.0 or Days Sales Outstanding of 44.7. TriSalus financial statements analysis is a perfect complement when working with TriSalus Life Valuation or Volatility modules.
TriSalus | Total Assets | Build AI portfolio with TriSalus Stock |
Latest TriSalus Life's Total Assets Growth Pattern
Below is the plot of the Total Assets of TriSalus Life Sciences over the last few years. Total assets refers to the total amount of TriSalus Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TriSalus Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. TriSalus Life's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 23.97 M | 10 Years Trend |
|
Total Assets |
| Timeline |
TriSalus Total Assets Regression Statistics
| Arithmetic Mean | 33,403,653 | |
| Geometric Mean | 32,570,001 | |
| Coefficient Of Variation | 21.30 | |
| Mean Deviation | 6,258,843 | |
| Median | 37,837,000 | |
| Standard Deviation | 7,114,725 | |
| Sample Variance | 50.6T | |
| Range | 16.3M | |
| R-Value | (0.79) | |
| Mean Square Error | 20T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | (1,117,292) | |
| Total Sum of Squares | 809.9T |
TriSalus Total Assets History
Other Fundumenentals of TriSalus Life Sciences
TriSalus Life Total Assets component correlations
Click cells to compare fundamentals
About TriSalus Life Financial Statements
Investors use fundamental indicators, such as TriSalus Life's Total Assets, to determine how well the company is positioned to perform in the future. Although TriSalus Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Assets | 21.6 M | 21.7 M | |
| Intangibles To Total Assets | 0.04 | 0.02 |
Currently Active Assets on Macroaxis
When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:Check out the analysis of TriSalus Life Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.